<DOC>
	<DOCNO>NCT02689713</DOCNO>
	<brief_summary>This study seek test study drug ( voriconazole ) , apply topically burn wound skin help reduce pain .</brief_summary>
	<brief_title>Pilot Study Compare Topical Voriconazole Placebo Pain Reducing Agent</brief_title>
	<detailed_description>This single-center , prospective , randomize , double-blind , control pilot study conduct San Antonio Military Medical Center evaluate effectiveness topical voriconazole pain relief autogenous skin donor site compare topical placebo application . The patient act control . All participant investigator study blind treatment arm utilize patient 's donor site ( voriconazole versus placebo ) . Patients , schedule skin graft meet inclusion criterion study , invite enroll study . Only patient plan skin graft site approximately symmetrical size allow enroll study . The donor site wound study use paired design consist voriconazole placebo apply topically same-patient matched donor site . Patients query via pain assessment tool perceive pain timed interval . Dialysate sample collect via microdialysis probe match timed interval order measure level oxidize linoleic acid metabolite show previous study present peripheral nerve .</detailed_description>
	<mesh_term>Hyperalgesia</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<criteria>1.1 Subject must least 18 year age old 60 year age either gender good general health . 1.2 Subject sustain burn wound less 30 percent total body surface area , order minimize systemic effect wound heal risk infection ( increase increase burn size ) . 1.3 Subject sustain Burn trauma/orthopedic wound involve harvest area . 1.4 Subject sustain burn trauma/orthopedic wound , judgment attend surgeon , require excision grafting sufficient extent justify two donor site equal symmetrical size nondependent body surface area . Note : Only two donor site study , however subject require two donor site , exclude . 1.5 The scheduled excision graft procedure first operation subject hospitalization injury . 1.6 Subject agrees participate followup evaluation ( Post Op Day 03 one follow appointment Post Op day 3045 Donor site evaluation photo donor site . 2.1 Critical illness require ventilator support , systemic infection hemodynamic instability , define mean arterial pressure le 60 extended period time require vasoactive medication support blood pressure . 2.2 Patients unable accurately communicate pain secondary medical illness , alter mental status , spinal cord injury , know current narcotic drug use . 2.3 Patients unable make his/her decision inform consent . ( Not seek consent legal authorize representative ; self consent ) . 2.4 Major acute chronic medical illness could affect wound healing ( e.g . peripheral vascular disease , blood clot disorder ) . 2.6 Cellulitis infection potential donor site . 2.7 Donor site previously harvest graft . 2.8 Donor site cross joint . 2.9 Any Corticosteroid use could interfere wound heal thus OLAM level . 2.10 Subjects great 30 % total body surface area burn . 2.11 Pregnancy lactation . ( Beta HCG pregnancy test complete prior operative procedure , part study ) In event record hysterectomy , pregnancy test do , subject assume NOT pregnant . 2.12 Prisoners . 2.13 Subjects contraindication voriconazole . The contraindication 1 ) know hypersensitivity voriconazole ; 2 ) Coadministration terfenadine , astemizole , cisapride , pimozide , quinidine sirolimus , rifampin , carbamazepine , long act barbiturate , high dose ritonavir , rifabutin , ergotamine , dihydroergotamine , oral contraceptive St. John 's Wort . A one week washout shall determine listed medication prior allow entry study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Burn Pain</keyword>
	<keyword>Hyperalgesia</keyword>
	<keyword>TRPV1</keyword>
	<keyword>OLAMs</keyword>
</DOC>